[Nasal myiasis due to lucilia sp. in intubated patient: about one case in Morocco]

Manal Bouikhif1,2, Yasmine El Kettani1,2, Mohamed Lyagoubi1,2

  • 1Laboratoire central de parasitologie et mycologie, Centre hospitalier universitaire Ibn Sina, Rabat, Maroc.

Abstract

Insights

This case highlights rare nasal myiasis in an intensive care unit (ICU) patient. Prompt larval identification and removal are crucial for managing this unusual hospital-acquired infestation.

Area of Science:

  • Medical Entomology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Myiasis is the infestation of humans and animals by fly larvae.
  • Hospital-acquired myiasis is rare, often occurring in patients with open wounds or body cavities.
  • Intensive care unit (ICU) environments present unique risks due to patient immobility and potential attractants.

Observation:

  • A case of nasal myiasis occurred in a 72-year-old patient admitted to the ICU for septic shock.
  • Maggots, identified as third-stage larvae of *Lucilia* sp., were observed in the patient's nasal cavity.
  • Larvae were successfully removed via nasal washing, with no further infestation noted.

Findings:

  • Nasal myiasis in an ICU setting is an extremely rare occurrence.
  • Factors contributing to ICU myiasis include patient's compromised state and environmental conditions.
  • Despite successful larval removal, the patient succumbed to septic shock.

Implications:

  • This case underscores the importance of vigilance for unusual infections in ICUs.
  • Effective fly control measures are essential to prevent hospital-acquired myiasis.
  • Underreporting of ICU myiasis may necessitate improved surveillance and prevention strategies.